Phase 1 Trials at Nebraska Cancer Specialists

Nebraska Cancer Specialists is one of only a small group of leading community oncology practices in the country to offer an array of phase 1 trials.

Phase I trials generally evaluate the safety of a new drug or new combinations of drugs. Typically they involve a small number of patients for whom standard therapies have proven ineffective and seek to determine a safe dose level and obtain a preliminary assessment of efficiency. Patients benefit from a range of trials that would typically only be found at large academic research centers, but offered in the convenience and personal care of a private practice.

Our robust Research Department is helping advance cancer research, while offering hope to patients fighting the toughest battles. Through phase I trials, we are able offer first ever access to clinical trial treatments and therapies. Our research department has experience in delivering first-in-human drug trials including studies in which we have treated the first patient ever with new drugs.

When a patient is deemed eligible for a phase 1 trial, they experience an added level of care. In addition to our standard oncology team of physicians, nurse practitioners and case managers, patients in phase I trials will be working closely hand-in-hand with our Research Team.

Are You a Provider

Contact Us to Discuss Available Clinical Trial Options for Your Patients

For a list of 100+ available clinical trials, contact Megan Meays, Research Director | mmeays@nebraskacancer.com